EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Adjuvant COX inhibition augments STING signaling and cytolytic T cell infiltration in irradiated 4T1 tumors

Lisa A Ridnour, Robert Ys Cheng, Noemi Kedei, Veena Somasundaram, Dibyangana D Bhattacharyya, Debashree Basudhar, Adelaide L Wink, Abigail J Walke, Caleb Kim, William F Heinz, Elijah F Edmondson, Donna O Butcher und 18 weitere

JCI Insight · 24.06.2024 · 9 (12)

DOI: 10.1172/jci.insight.165356 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JCI Insight, online erschienen am 21.05.2024. Verfasst von Lisa A Ridnour und 29 weiteren Autor:innen. Beteiligte Einrichtung: Cancer Innovation Laboratory, CCR, NCI, NIH, Frederick, Maryland, USA. Hauptthemen laut MEDLINE: Membrane Proteins, Signal Transduction, T-Lymphocytes, Cytotoxic. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, Cancer Research UK, CCR NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Immune therapy is the new frontier of cancer treatment. Therapeutic radiation is a known inducer of immune response and can be limited by immunosuppressive mediators including cyclooxygenase-2 (COX2) that is highly expressed in aggressive triple negative breast cancer (TNBC). A clinical cohort of TNBC tumors revealed poor radiation therapeutic efficacy in tumors expressing high COX2. Herein, we show that radiation combined with adjuvant NSAID (indomethacin) treatment provides a powerful combination to reduce both primary tumor growth and lung metastasis in aggressive 4T1 TNBC tumors, which occurs in part through increased antitumor immune response. Spatial immunological changes including augmented lymphoid infiltration into the tumor epithelium and locally increased cGAS/STING1 and type I IFN gene expression were observed in radiation-indomethacin–treated 4T1 tumors. Thus, radiation and adjuvant NSAID treatment shifts “immune desert phenotypes” toward antitumor M1/TH1 immune mediators in these immunologically challenging tumors. Importantly, radiation-indomethacin combination treatment improved local control of the primary lesion, reduced metastatic burden, and increased median survival when compared with radiation treatment alone. These results show that clinically available NSAIDs can improve radiation therapeutic efficacy through increased antitumor immune response and augmented local generation of cGAS/STING1 and type I IFNs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Membrane ProteinsSignal TransductionT-Lymphocytes, CytotoxicAnimalsMiceFemaleTriple Negative Breast NeoplasmsIndomethacinCell Line, TumorHumansLung NeoplasmsCyclooxygenase InhibitorsNucleotidyltransferasesInterferon Type ICyclooxygenase 2Lymphocytes, Tumor-InfiltratingMice, Inbred BALB CSTING Protein

Stichwörter der Autor:innen

Adaptive immunityBreast cancerInflammationOncology

Substanzen

Membrane ProteinsIndomethacinCyclooxygenase InhibitorsNucleotidyltransferasesInterferon Type ICyclooxygenase 2Sting1 protein, mouseSTING Protein

Autor:innen und Institutionen

  • Cancer Innovation Laboratory, CCR, NCI, NIH, Frederick, Maryland, USA.
  • Collaborative Protein Technology Resource (CPTR) Nanoscale Protein Analysis, OSTR, CCR, NCI, NIH, Bethesda, Maryland, USA.
  • Optical Microscopy and Analysis Laboratory, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, and.
  • Molecular Histopathology Laboratories, Leidos Biomedical Research Inc. for the National Cancer Institute, Frederick, Maryland, USA.
  • Laboratory of Human Carcinogenesis, CCR, NCI, NIH, Bethesda, Maryland, USA.
  • Imaging Mass Cytometry Frederick National Laboratory for Cancer Research, and.

Förderung

  • NCI NIH HHS
  • Cancer Research UK
  • CCR NIH HHS

Zitieren

APA

Ridnour, L. A., Cheng, R. Y., Kedei, N., Somasundaram, V., Bhattacharyya, D. D., Basudhar, D., Wink, A. L., Walke, A. J., Kim, C., Heinz, W. F., Edmondson, E. F., Butcher, D. O., Warner, A. C., Dorsey, T. H., Pore, M., Kinders, R. J., Lipkowitz, S., Bryant, R. J., Rittscher, J., …, & Wink, D. A. (2024). Adjuvant COX inhibition augments STING signaling and cytolytic T cell infiltration in irradiated 4T1 tumors. JCI Insight, 9(12). https://doi.org/10.1172/jci.insight.165356

Vancouver

Ridnour LA, Cheng RY, Kedei N, Somasundaram V, Bhattacharyya DD, Basudhar D, et al. Adjuvant COX inhibition augments STING signaling and cytolytic T cell infiltration in irradiated 4T1 tumors. JCI Insight. 2024;9(12). doi:10.1172/jci.insight.165356

BibTeX
@article{Ridnour2024,
  author = {Ridnour, Lisa A and Cheng, Robert Ys and Kedei, Noemi and Somasundaram, Veena and Bhattacharyya, Dibyangana D and Basudhar, Debashree and Wink, Adelaide L and Walke, Abigail J and Kim, Caleb and Heinz, William F and Edmondson, Elijah F and Butcher, Donna O and Warner, Andrew C and Dorsey, Tiffany H and Pore, Milind and Kinders, Robert J and Lipkowitz, Stanley and Bryant, Richard J and Rittscher, Jens and Wong, Stephen Tc and Hewitt, Stephen M and Chang, Jenny C and Shalaby, Aliaa and Callagy, Grace M and Glynn, Sharon A and Ambs, Stefan and Anderson, Stephen K and McVicar, Daniel W and Lockett, Stephen J and Wink, David A},
  title = {Adjuvant COX inhibition augments STING signaling and cytolytic T cell infiltration in irradiated 4T1 tumors},
  journal = {JCI Insight},
  year = {2024},
  volume = {9},
  number = {12},
  doi = {10.1172/jci.insight.165356}
}
Kostenlos starten →